Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Gehan

Showing results (31-40 of 147) with videos related to

Pageof 15
Sort By:
National Cancer Institute Monograph|April 1, 1981
Radiation therapy combined with systemic chemotherapy of rhabdomyosarcoma in children: local control in patients enrolled in the Intergroup Rhabdomyosarcoma StudyM Tefft, R D Lindberg, E A Gehan
Controlled Clinical Trials|December 10, 1999
A modification of Simon's optimal design for phase II trials when the criterion is median sample sizeJ J Hanfelt, R S Slack, E A Gehan
Cancer Treatment Reports|February 1, 1980
Use of prognostic factors in analysis of historical control studiesE A Gehan, T L Smith, A U Buzdar
Cancer|September 26, 1997
Pretreatment TNM staging of childhood rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group. Children's Cancer Study Group. Pediatric Oncology GroupW Lawrence, J R Anderson, E A Gehan, et al.
Skeletal Radiology|January 1, 1992
Plain radiographic predictors of survival in treated Ewing's sarcoma. IESS CommitteeW R Reinus, E A Gehan, L A Gilula, et al.
The American Journal of the Medical Sciences|September 1, 1971
Protected environment-prophylactic antibiotic program in the chemotherapy of acute leukemiaG P Bodey, E A Gehan, E J Freireich, et al.
Statistics in Medicine|September 15, 1994
An optimal three-stage design for phase II clinical trialsL G Ensign, E A Gehan, D S Kamen, et al.
Cancer|August 1, 1982
Prediction of remission in adult acute leukemia: development and testing of predictive modelsT L Smith, E A Gehan, M J Keating, et al.
Cancer|July 1, 1990
Treatment of lower torso stages I and II Hodgkin's disease with radiation with or without adjuvant mechlorethamine, vincristine, procarbazine, and prednisoneS S Givens, L M Fuller, F B Hagemeister, et al.
The Journal of Clinical Investigation|September 1, 1983
Marrow cytometry and prognosis in myelomaB Barlogie, R Alexanian, E A Gehan, et al.
Pageof 15

Showing results (31-40 of 147) with videos related to

Sort By:
Pageof 15
National Cancer Institute Monograph|April 1, 1981
Radiation therapy combined with systemic chemotherapy of rhabdomyosarcoma in children: local control in patients enrolled in the Intergroup Rhabdomyosarcoma StudyM Tefft, R D Lindberg, E A Gehan
Controlled Clinical Trials|December 10, 1999
A modification of Simon's optimal design for phase II trials when the criterion is median sample sizeJ J Hanfelt, R S Slack, E A Gehan
Cancer Treatment Reports|February 1, 1980
Use of prognostic factors in analysis of historical control studiesE A Gehan, T L Smith, A U Buzdar
Cancer|September 26, 1997
Pretreatment TNM staging of childhood rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group. Children's Cancer Study Group. Pediatric Oncology GroupW Lawrence, J R Anderson, E A Gehan, et al.
Skeletal Radiology|January 1, 1992
Plain radiographic predictors of survival in treated Ewing's sarcoma. IESS CommitteeW R Reinus, E A Gehan, L A Gilula, et al.
The American Journal of the Medical Sciences|September 1, 1971
Protected environment-prophylactic antibiotic program in the chemotherapy of acute leukemiaG P Bodey, E A Gehan, E J Freireich, et al.
Statistics in Medicine|September 15, 1994
An optimal three-stage design for phase II clinical trialsL G Ensign, E A Gehan, D S Kamen, et al.
Cancer|August 1, 1982
Prediction of remission in adult acute leukemia: development and testing of predictive modelsT L Smith, E A Gehan, M J Keating, et al.
Cancer|July 1, 1990
Treatment of lower torso stages I and II Hodgkin's disease with radiation with or without adjuvant mechlorethamine, vincristine, procarbazine, and prednisoneS S Givens, L M Fuller, F B Hagemeister, et al.
The Journal of Clinical Investigation|September 1, 1983
Marrow cytometry and prognosis in myelomaB Barlogie, R Alexanian, E A Gehan, et al.
Pageof 15